Coronary Artery Bypass Graft Surgery(CABG)VR-CABGNCT07891299

VR During Chest Tube Removal After CABG

A study testing VR Shinecon G04EA Virtual Reality Headset in people with Coronary Artery Bypass Graft Surgery(CABG) and Postoperative Pain Management, run by Maltepe University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

he purpose of this clinical trial is to evaluate whether virtual reality can reduce pain, anxiety, and physiological stress during chest tube removal in adult patients undergoing coronary artery bypass graft (CABG) surgery. Read more about this study

Who is it for?: Ages 18 to 65 years
Conditions the study is for: Coronary Artery Bypass Graft Surgery(CABG), Postoperative Pain Management
What is being tested?: VR Shinecon G04EA Virtual Reality Headset
Type of treatment: Medical device
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 82 participants
Where: 1 siteTurkey (Türkiye)
Study dates: 5 Dec 2024to 2 Mar 2026
Phase: Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 to 65 years
All sexes
No healthy volunteers
Adult, Older adult

Who may be able to join

Age between 18 and 65 years
Undergoing coronary artery bypass graft surgery
Presence of chest tube
Conscious and oriented
Able to communicate in Turkish
Voluntarily agrees to participate

Who cannot join

Chronic pain condition requiring regular analgesic use
Migraine, vertigo, or history of dizziness
Visual impairment preventing VR use
Psychiatric disorders
Undergoing different cardiac surgical procedures
Refusal to participate

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site

Maltepe University
Istanbul, 0000

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Virtual Reality During Chest Tube Removal in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial

The main questions it aims to answer are:

Does virtual reality reduce pain intensity during chest tube removal?
Does virtual reality reduce anxiety levels and stabilize vital signs? Researchers will compare patients receiving virtual reality with patients receiving routine care to determine whether virtual reality improves patient comfort during the procedure.

Participants will:

Be randomly assigned to a virtual reality group or a control group
Have their pain, anxiety, and vital signs measured before the procedure
Undergo chest tube removal with or without virtual reality
Have their pain, anxiety, and vital signs measured again after the procedure

Conditions: Coronary Artery Bypass Graft Surgery(CABG), Postoperative Pain Management
Being tested: VR Shinecon G04EA Virtual Reality Headset
Keywords: Coronary Artery Bypass, Surgery, Virtual Reality, Pain, Vital Signs, Anxiety
Medical subject headings: Pain, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

VR Shinecon G04EA Virtual Reality HeadsetDevice
Participants in the experimental group receive a virtual reality intervention using the VR Shinecon G04EA virtual reality headset, which displays immersive nature videos accompanied by audio. The intervention begins 5 minutes before chest tube removal and continues throughout the procedure. The virtual reality headset is used as a non-pharmacological distraction method to reduce pain and anxiety associated with chest tube removal. The intervention is administered in addition to routine postoperative care in the cardiovascular intensive care unit following coronary artery bypass graft surgery.

Study groups in NCT07891299
Study group	Role	What they receive
Virtual Reality Group	Experimental	Patients in the experimental group received a virtual reality intervention using a virtual reality headset during chest tube removal following coronary artery bypass graft surgery, in addition to standard care. The intervention was designed to reduce pain and anxiety associated with chest tube removal. Receives: Device: VR Shinecon G04EA Virtual Reality Headset
Control Group	No intervention	Control

What is being measured

The primary outcome is the main question the study is designed to answer.

Pain Intensity (VAS)
Pain intensity is assessed using the Visual Analog Scale (VAS), with scores ranging from 0 to 10. A score of 0 indicates no pain, while a score of 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Measured: Immediately before and immediately after chest tube removal

Secondary outcomes (1)

Anksiyete - State-Trait Anxiety Inventory (STAI-State)
Anxiety is assessed using the State Anxiety Inventory (STAI-State). Total scores range from 20 to 80, with higher scores indicating greater levels of state anxiety.
Measured: Before chest tube removal (baseline) and immediately after completion of chest tube removal (post-intervention).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

5 Dec 20242 Mar 2026

First posted23 Oct 2026
Study start5 Dec 2024
Primary completion5 Jan 2026
Study completion2 Mar 2026

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for Coronary Artery Bypass Graft Surgery(CABG)Studies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Other
Allocation: Randomised
Intervention model: Parallel groups
Masking: None (open label)
Enrolment: 82 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT07891299
Sponsor's protocol ID: MU-SN-2024-VR-CABG-01
Other IDs: Master's Thesis Study - Maltep
Acronym: VR-CABG
Status last verified: Oct 2026
First submitted: 15 Oct 2026
Last updated: 23 Oct 2026
Results posted: No
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Not yet recruiting
BRIDGE Trial: Embedding Consumer-grade mHealth Technologies Into Cardiac Rehabilitation
Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI)
Not yet recruitingPhase 3
A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.
Coronary Artery Disease (CAD), Coronary Artery Bypass Graft Surgery(CABG)
Active, not recruiting
A Single Centre Study Comparing Continuous Interstitial Fluid Lactate Detection to Standard Measurements of Lactate in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery and/or Valve Replacement.
Coronary Artery Bypass, Coronary Artery Bypass Graft
Not yet recruitingObservational study
Mechanical Power and Pulmonary Complications in CABG Surgery
Postoperative Pulmonary Complications, Coronary Artery Bypass Graft Surgery (CABG)
RecruitingObservational study
Graft Failure and Consequences of Coronary Artery Bypass Graft Surgery
Coronary Artery Bypass, Graft Failure

All Coronary Artery Bypass Graft Surgery(CABG) trials